Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy
Assessment of Cognitive Ability and the Intestinal Microbiome in Individuals With Liver Disease Before and After Investigational Microbiota Restoration Therapeutic
Sponsor: Ochsner Health System
Terminated
Unable to recruit participants
Other terminated trials from Ochsner Health System
Other Cirrhosis, Liver trials with similar outcome
This PHASE2 trial investigates Cirrhosis, Liver and Hepatic Encephalopathy and is currently terminated or withdrawn. Ochsner Health System leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Nov 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
May 2023 — Nov 2023 [monthly]
Recruiting PHASE2
-
Oct 2021 — May 2023 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ochsner Health System
- Rebiotix Inc.
For direct contact, visit the study record on ClinicalTrials.gov .